Dellora Investments logo

Dellora Investments

North America, Connecticut, United States, Greenwich

Description

Dellora Investments is an investment firm.

Investor Profile

Dellora Investments has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biotechnology, Medical, Therapeutics.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dellora Investments frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 1
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 1
SC
North America, Massachusetts, United States, Boston
Co-Investments: 1
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 1
6C
North America, New York, United States, New York
Co-Investments: 1
RTW Investments
North America, New York, United States, New York
Co-Investments: 1
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
Armistice Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Dellora Investments?

immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Post Ipo EquityOct 10, 2022
Amount Raised: $110,000,000